Clinical trial
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00327197 |
|---|---|
| Title | Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma |
| Official title | A Study to Assess Disease Pathology and Key Therapeutic Targets in Severe Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug, Procedure |
| Interventions | Prednisolone, Bronchoscopy |
| Enrollment | 47 |
| Start date | Aug 2, 2005 |
| Primary completion | Jun 6, 2011 |
| Completion | Jun 6, 2011 |
| First posted | May 18, 2006 |
| Last update posted | Aug 4, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: